Announcing the Formation of VaxCorps, a Network of Clinical Research Centers Specializing in Vaccine Trials

Three powerhouses of clinical research, Benchmark Research, Miami Research Associates (MRA) and Piedmont Medical Group (PMG) have joined together to form VaxCorps.

Austin, Texas (PRWEB) March 23, 2015 -- Benchmark Research, Miami Research Associates (MRA), and Piedmont Medical Group (PMG) are pleased to announce the formation of VaxCorps, a network of highly experienced, geographically diverse clinical research centers specializing in the conduct of vaccine trials in healthy adult, elderly, and pediatric populations. VaxCorps clinical sites have successfully conducted over 500 phase I-IV vaccine clinical trials, with extensive experience in seasonal and pandemic influenza as well as a vast array of other infectious and biodefense vaccine indications. As industry leaders, VaxCorps is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup and enrollment, and outstanding subject retention as top priorities.

Though the VaxCorps name is new, the players are all well known and highly respected in the industry. As a testament to this, Benchmark, MRA, and PMG were all recently selected by their clients and peers as finalists for Best Clinical Trial Site or Network at the 2015 World Vaccine Congress’ Vaccine Industry Excellence Awards. Most noteworthy of all, VaxCorps members comprise 50% of the pool of finalists. Come to the meeting to see which site will take home the award and be sure to visit VaxCorps at booth #40 to learn more about this exciting, new initiative.